OvaScience Inc (NASDAQ:OVAS) announced a business update. The Company will continue to make AUGMENT available to patients at partner clinics in Canada and Japan …
OvaScience Inc (NASDAQ:OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced that it has finalized …
OvaScience Inc (NASDAQ:OVAS) just reported second-quarter earnings, but for JMP Securities analyst Michael King, the true assessment of OVAS as an investing opportunity …
Abercrombie & Fitch Co. (NYSE:ANF) is down close to 12% in pre-market trading after the firm released disappointing 1Q:16 earnings this morning.
OvaScience Inc (NASDAQ:OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it has priced its …
OvaScience Inc (NASDAQ:OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced today that it has commenced …
OvaScience Inc (NASDAQ:OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, announced thatArthur Tzianabos, Ph.D.
The actions of insiders often reflect their opinion of where the company is headed. A CFO is unlikely to buy shares of the company if …
OvaScience Inc (NASDAQ:OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today reported fourth quarter and year …
OvaScience Inc (NASDAQ:OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced Paul W.D.
